TwinBeech Capital’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,445
| Closed | -$216K | – | 1017 |
|
|
2025
Q1 | $216K | Buy |
+6,445
| New | +$216K | ﹤0.01% | 652 |
|
|
2024
Q3 | – | Sell |
-88,711
| Closed | -$3.46M | – | 932 |
|
|
2024
Q2 | $3.46M | Sell |
88,711
-9,331
| -10% | -$364K | 0.07% | 264 |
|
|
2024
Q1 | $4.22M | Buy |
+98,042
| New | +$4.22M | 0.09% | 239 |
|
|
2023
Q1 | – | Sell |
-101,717
| Closed | -$4.01M | – | 928 |
|
|
2022
Q4 | $4.01M | Buy |
101,717
+52,967
| +109% | +$2.09M | 0.08% | 302 |
|
|
2022
Q3 | $1.76M | Buy |
48,750
+37,727
| +342% | +$1.36M | 0.05% | 359 |
|
|
2022
Q2 | $335K | Sell |
11,023
-16,445
| -60% | -$500K | 0.02% | 447 |
|
|
2022
Q1 | $840K | Buy |
27,468
+20,590
| +299% | +$630K | 0.04% | 338 |
|
|
2021
Q4 | $215K | Buy |
+6,878
| New | +$215K | 0.01% | 513 |
|